Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk
Junjie Qian,Limin Ding,Qinchuan Wu,Xizhi Yu,Qiyong Li,Yangjun Gu,Shuai Wang,Jing Mao,Xi Liu,Bohan Li,Caixu Pan,Wenchao Wang,Yubo Wang,Jianpeng Liu,Yiting Qiao,Haiyang Xie,Tianchi Chen,Jiangzhen Ge,Lin Zhou,Shengyong Yin,Shusen Zheng
DOI: https://doi.org/10.1016/j.canlet.2023.216514
IF: 9.756
2023-11-01
Cancer Letters
Abstract:CD103<sup>+</sup> DC is crucial for antitumor immune response. As a promising local therapy on cancers, nanosecond pulsed electric field (nsPEF) has been widely reported to stimulate anti-tumor immune response, but the underlying relationship between intratumoral CD103<sup>+</sup> DC and nsPEF treatment remains enigmatic. Here, we focused on the behavior of CD103<sup>+</sup> DC in response to nsPEF treatment and explored the underlying mechanism. We found that the nsPEF treatment led to the activation and accumulation of CD103<sup>+</sup> DC in tumor. Depletion of CD103<sup>+</sup> DC via Batf3<sup>-/-</sup> mice demonstrated CD103<sup>+</sup> DC was necessary for intratumoral CD8<sup>+</sup> T cell infiltration and activation in response to nsPEF treatment. Notably, NK cells recruited CD103<sup>+</sup> DC into nsPEF-treated tumor through CCL5. Inflammatory array revealed CD103<sup>+</sup> DC-derived IL-12 mediated the CCL5 secretion in NK cells. In addition, the boosted activation and infiltration of intratumoral CD103<sup>+</sup> DC were abolished by cGAS-STING pathway inhibition, following IL-12 and CCL5 decreasing. Furthermore, nsPEF treatment promoting CD103<sup>+</sup> DC-mediated antitumor response enhanced the effects of CD47 blockade strategy. Together, this study uncovers an unprecedented role for CD103<sup>+</sup> DC in nsPEF treatment-elicited antitumor immune response and elucidates the underlying mechanisms.
oncology